Lariago 50mg Suspension
- Manufacturer : Ipca Laboratories Ltd.
- Composition : Chloroquine 50mg
- Generally Prescribed For : Malarial
- Estimated Price : ₹17.00 For 60ml Bottle
BUY FROM THESE SELLERS
Uses of Lariago 50mg SuspensionLariago 50mg Suspension is used for the treatment or prevention of the following disease(s):
Side effects of Lariago 50mg SuspensionThe most common side effects of Lariago 50mg Suspension are - Seizures, Mild and Transient Headache, Psychic Stimulation, Neuropathy, Acute Extrapyramidal, Anorexia, Abdominal Cramps, Diarrhea, Nausea, Vomiting
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Lariago 50mg SuspensionDo not use Lariago 50mg Suspension if you are allergic to - Chloroquine
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Lariago 50mg Suspension.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Lariago 50mg Suspension worksLariago 50mg Suspension contains - Chloroquine
Chloroquine may bind to and alter the properties of DNA in susceptible parasites.
Dosage of Lariago 50mg SuspensionThe dosage of Lariago 50mg Suspension depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Lariago 50mg SuspensionIf you forget to take a dose of Lariago 50mg Suspension, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
InteractionDrug :- Aluminum salts (kaolin), magnesium: May decrease GI absorption. Separate dose times by 4 hours.
Ampicillin: May significantly reduce bioavailability of ampicillin. Separate dose times by 2 hours.
Cimetidine: May decrease hepatic metabolism of chloroquine. Monitor patient for toxicity.
Cyclosporine: May cause a sudden increase in serum cyclosporine level. Monitor patient closely. If necessary, discontinue chloroquine.
Drugs that prolong QT interval: May have additive effects on QT interval. Avoid concurrent use if possible.
Mefloquine: May increase seizure risk. Avoid concurrent use, and delay administration of mefloquine until at least 12 hours after the last dose of chloroquine when possible.